NCT03802734

Brief Summary

There is evidence to show that mindful meditation has a positive impact on health. To date, all the studies done to investigate the effect of mindfulness on pregnancy outcomes have been done through a traditional 8-10 weeks mindfulness classroom program with some home practice. This time-intensive classroom training may be expensive and not convenient for many busy pregnant women. This study will investigate the use of a smartphone app-based intervention to determine if it has the potential to make mindfulness training more accessible, acceptable, and convenient to a larger number of pregnant women. The use of an app as opposed to traditional structured classes may increase a woman's ability and willingness to practice mindfulness because the app can be used almost anywhere and at any time. This pilot study aims to explore the feasibility and acceptability of a smartphone mindfulness meditation application for pregnant women. As well, this study will compare the pregnancy outcomes of women who use the app to those women who do not use the app.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
128

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2018

Completed
25 days until next milestone

First Posted

Study publicly available on registry

January 14, 2019

Completed
7 months until next milestone

Study Start

First participant enrolled

August 15, 2019

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 2, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 2, 2021

Completed
Last Updated

December 9, 2019

Status Verified

December 1, 2019

Enrollment Period

1.4 years

First QC Date

December 20, 2018

Last Update Submit

December 5, 2019

Conditions

Outcome Measures

Primary Outcomes (6)

  • Sleep

    Sleep/wake cycles as measured by an accelerometer that measures tri-axial movement (i.e., actigraphy) for qualitative assessment of sleep.

    20 weeks gestation to 6 weeks post partum

  • Use of Meditation Phone App - minutes per day

    Measured use of the Headspace app in minutes per day

    20 weeks gestation to 6 weeks post partum

  • Use of Meditation Phone App - sessions completed

    Measured use of the Headspace app in total number of sessions completed

    20 weeks gestation to 6 weeks post partum

  • Use of Meditation Phone App - type of sessions

    Breakdown of the number of different session-types used

    20 weeks gestation to 6 weeks post partum

  • Use of Meditation Phone App - average session length

    Average session length (in minutes)

    20 weeks gestation to 6 weeks post partum

  • Use of Meditation Phone App - total time spent meditating

    Total number of minutes spent meditating using the meditation phone app

    20 weeks gestation to 6 weeks post partum

Secondary Outcomes (6)

  • Pittsburgh Sleep Quality Index (PSQI)

    PSQI will be completed at 3 time-points: <= 20 weeks gestation, 35-40 weeks gestation, 6 weeks post-partum.

  • Perceived Stress Scale (PSS)

    PSS will be completed at 3 time-points: <= 20 weeks gestation, 35-40 weeks gestation, 6 weeks post-partum.

  • Edinburgh Postnatal Depression Scale (EPDS)

    EDPS will be completed at 3 time-points: <= 20 weeks gestation, 35-40 weeks gestation, 6 weeks post-partum.

  • Beck Anxiety Inventory (BAI)

    20 weeks gestation to 6 weeks post partum

  • Complications during pregnancy

    Beginning of pregnancy to delivery

  • +1 more secondary outcomes

Study Arms (2)

Mindful Meditation App

EXPERIMENTAL

Group A will be given a free subscription to a mindful meditation phone app for six months. They will also be given an actigraph and a general pregnancy and sleep information leaflet.

Device: Mindful meditation phone app

No Meditation App

NO INTERVENTION

Group B will be given an actigraph and a general pregnancy and sleep information leaflet only.

Interventions

Participants in the intervention group will be given a free 6-month subscription to a mindful meditation phone app (Headspace). They will also be given an actigraph and a general pregnancy and sleep information leaflet.

Mindful Meditation App

Eligibility Criteria

Age16 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant women
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Are able to understand and sign this consent form
  • Have a singleton pregnancy (not having twins)
  • Are planning to give birth at St. Michael's Hospital
  • Have access to personal email, a smartphone, and have a data plan
  • Are able to understand and write English
  • Are 20-30 weeks into your pregnancy

You may not qualify if:

  • Are formally practicing a body-mind activity (except yoga) or currently using a mindfulness/meditation app
  • Have a known psychiatric diagnosis or acute psychiatric illness (substance dependence or abuse, history of schizophrenia or other psychotic disorders, eating disorders, etc.)
  • Have a mood disorder and/or suicide risk
  • Have any medical, infectious, or degenerative disease that may affect mood, behavior, and stress levels
  • Have a known fetal anomaly
  • Have an uncontrolled medical condition that may interfere with sleep or requires immediate treatment
  • Have a comorbid sleep disorder, including obstructive sleep apnea, restless legs syndrome, or circadian rhythm sleep disorders
  • Are using hypnotic or sedating medications, antidepressant or antipsychotic medications, or currently under psychopharmacological, behavioral, or psychoanalytic treatment
  • Are a night shift worker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Michael's Hospital

Toronto, Ontario, M5B1W8, Canada

Location

Study Officials

  • Howard Berger, MD

    Unity Health Toronto

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Randomized control trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2018

First Posted

January 14, 2019

Study Start

August 15, 2019

Primary Completion

January 2, 2021

Study Completion

January 2, 2021

Last Updated

December 9, 2019

Record last verified: 2019-12

Locations